The most effective natural Energy treatment
Click on a box to see what we consider
the most effective natural Energy treatment for you

WOMEN 39
AND UNDER		 MEN 39
AND UNDER		 WOMEN 40
AND UP		 MEN 40
AND UP
click here...click here...click here...click here...

Less energy
(chronic fatigue syndrome)

Fatigue and lack of energy is a very common symptom today. In case of acute fatigue without a direct cause, the patient should always be examined for possible undiagnosed illnesses. Most patients that complain of chronic fatigue do not usually suffer from a traditional disease. Rather, it is often due, among other things, to a chronic lack of essential nutrients, stress and the body producing less coenzyme Q10.

By the age of 40, the body’s own capacity to produce coenzyme Q10 falls drastically and many people consequently feel more tired. Most people suffering from various degrees of chronic fatigue, ruling out other possible causes, experience a significant increase in energy when they start taking coenzyme Q10 supplements in addition to other essential nutrients.

Which natural ingredients can have an effect on energy?

Coenzyme Q10, Siberian ginseng, chromium, selenium, zinc, magnesium in addition to most vitamins can stimulate energy synthesis.

Other recommendations for treatment:

  • Stress management – plan your day realistically.
  • Eat fewer carbohydrates and do not eat just before going to bed.
  • Do moderate exercise on a regular basis.
  • Avoid food substances you do not tolerate.

What effects do these ingredients have?

  • Enhance energy.
  • Improve quality of sleep.
  • Reduce stress.
  • Increase the natural urge to have sex.
  • Increase mental alertness and physical endurance.

For the reader with a deeper interest:

How do these ingredients work?

  • Treat and prevent vitamin and mineral deficiencies.
  • Increase the production of energy in the body by ATP synthesis.
  • Enhance stress-tolerance by lowering adrenaline, among others.
  • Antioxidant effect.
  • Anti-inflammatory effect.
  • Increase insulin synthesis and normalize blood sugar level.
  • Strengthen the body’s immune system.
  • Inhibit oxidation of fatty substances, such as LDL (unhealthy) cholesterol.
  • Lower high blood pressure by reducing peripheral vascular resistance.
  • Coenzyme Q10 and Siberian ginseng mechanisms of action:
  • Coenzyme Q10 is synthesized in the body by a 17-hour long process, which demands the presence of at least seven vitamins (B2, B3, B6, B12, C, folic acid and pantotene acid), including several trace minerals.
  • Coenzyme Q10 is a coenzyme for at least three enzymes related to mitochondria and is of vital importance to the production of "high in energy" adenosine triphosphate (ATP), which almost all cellular functions depend on. Siberian ginseng lowers elevated stress hormone levels in the blood, normalizes the adrenergic glandular function and excretes toxins.

The information above is based on more than 5,200 articles published in scientific journals and which are available at MEDLINE, the world's largest medical database. Below you will find a few of them listed:

References

  1. Alleva R, Scararmucci A, Mantero F, et al. The protective role of ubiquinol-10 against formation of lipid hydroperoxides in human seminal fluid. Mol Aspects Med. 1997;18(Suppl):S221-8.
  2. American Herbal Products Association. Use of Marker Compounds in Manufacturing and Labeling Botanically Derived Dietary Supplements. Silver Spring, MD: American Herbal Products Association; 2001.
  3. Artuch R, Vilaseca MA, Moreno J, et al. Decreased serum ubiquinone-10 concentrations in phenylketonuria. Am J Clin Nutr 1999;70:892–5.
  4. Asano K, Takahashi T, Miyashita M, et al. Effect of Eleutherococcus senticosus extract on human working capacity. Planta Medica 1986;37:175–7.
  5. Bargossi AM, Grossi G, Fiorella PL, Gaddi A, Di Giulio R, Battino M. Exogenous CoQ10 supplementation prevents plasma ubiquinone reduction by HMG-CoA reductase inhibitors. Mol Aspects Med. 1994;15(Suppl):S187-S193.
  6. Ben-Hur E, Fulder S. Effect of P. Siberian ginseng saponins and Eleutherococcus S. on survival of cultured mammalian cells after ionizing radiation. Am J Chin Med 1981;9:48–56.
  7. Bohn B, Nebe CT, Birr C. Flow cytometric studies with Eleutherococcus senticosus extract as an immunomodulating agent. Arzneim-Forsch Drug Res 1987;37:1193–6.
  8. Brown DJ. Herbal Prescriptions for Better Health. Rocklin, CA: Prima Publishing, 1996, 69–77.
  9. Burke BE  & al. Randomized, double-blind, placebo-controlled trial of coenzyme Q10 in isolated systolic hypertension. South Med J, 94(11): 1112-7   2002
  10. Chan A, Reichmann H, Kogel A, Beck A, Gold R. Metabolic changes in patients with mitochondrial myopathies and effects of Coenzym Q10 therapy. J Neurol. 1998;245:681-685.
  11. Chopra RK, Goldman R, Sinatra ST, Bhagavan HN. Relative bioavailability of Coenzym Q10 formulations in human subjects. Int J Vitam Nutr Res 1998;68:109–13.
  12. Collisson RJ. Siberian Siberian ginseng (Eleutherococcus senticosus). Brit J Phytother 1991;2:61–71 [review].
  13. Danysz A, Oledzka K, Bukowska-Kiliszek M. Influence of Coenzym Q-10 on the hypotensive effects of enalapril and nitrendipine in spontaneously hypertensive rats. Pol J Pharmacol. 1994;46(5):457-461.
  14. De Pinieux G, Chariot P, Ammi-Said M, et al. Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate levels. Br J Clin Pharmacol. 1996;42(3):333-337.
  15. Digiesi V, Cantini F, Bisi G, et al. Mechanism of action of Coenzym Q10 in essential hypertension. Curr Ther Res 1992;51:668–72.
  16. Ebadi M, Govitrapong P, Sharma S, at al. Ubiquinone (Coenzym q10) and mitochondria in oxidative stress of parkinson's disease. Biol Signals Recept. May2001;10(3-4):224-53.
  17. Farnsworth NR, et al. Siberian Siberian ginseng (Eleutherococcus senticosus): Current Status as an Adaptogen. In: Economics and Medicinal Plant Research. Vol 1. London: Academic Press; 1985:155-209.
  18. Farnsworth NR, Kinghorn AD, Soejarto DD, Waller DP. Siberian Siberian ginseng (Eleutherococcus senticosus): Current status as an adaptogen. In Economic and Medicinal Plant Research, vol 1, ed. Wagner H, Hikino HZ, Farnsworth NR. London: Academic Press, 1985, 155–215 [review].
  19. Filaretov AA, et al. Effect of Adaptogens on the Activity of the Pituitary-adrenocortical System in Rats. Biull Eksp Biol Med. 1986;101(5):573-74.
  20. Folkers K, et al. Two Successful Double-blind Trials with Coenzym Q10 (Vitamin Q10) on Muscular Dystrophies and Neurogenic Atrophies. Biochem Biophys Acta. May1995;1271(1):281-86.
  21. Folkers K, Shizukuishi S, Takemura K, et al. Increase in levels of IgG in serum of patients treated with Coenzym Q10. Res Commun Pathol Pharmacol 1982;38:335–8.
  22. Folkers K, Wolaniuk J, Simonsen R, et al. Biochemical rationale and the cardiac response of patients with muscle disease to therapy with Coenzym Q10. Proc Natl Acad Sci 1985;82:4513–6.
  23. Fujioka T, Sakamoto Y, Mimura G. Clinical study of cardiac arrhythmias using a 24-hour continuous electrocardiographic recorder (5th report)—antiarrhythmic action of Coenzym Q10 in diabetics. Tohoku J Exp Med 1983;141(suppl):453–63.
  24. Fulder SJ. Siberian ginseng and the Hypothalamic-pituitary Control of Stress. Am J Chin Med. 1981;9(2):112-18.
  25. Gaby AR. Coenzym Q10. In A Textbook of Natural Medicine, by Pizzorno JE, Murray MT. Seattle: Bastyr University Press, 1998, V:CoQ10–1–8. [review].
  26. Gaby AR. The role of Coenzym Q10 in clinical medicine: part II. Cardiovascular disease, hypertension, diabetes mellitus and infertility. Altern Med Rev 1996;1:168–75 [review].
  27. Haas EM. Staying Healthy with Nutrition. Berkley, Calif: Celestial Arts Publishing; 1992:65-79.
  28. Hansen IL, et al. Bioenergetics in Clinical Medicine. IX. Gingival and Leucocytic Deficiencies of Coenzym Q10 in Patients with Periodontal Disease. Res Commun Chem Pathol Pharmacol. Aug1976;14(4):729-38.
  29. Hikino H, et al. Isolation and Hypoglycemic Activity of Eleutherans A, B, C, D, E, F and G: Glycans of Eleutherococcus senticosus Roots. J Nat Prod. 1986;49(2):293-97.
  30. Hodgson JM & al , Coenzyme Q10 improves blood pressure and glycaemic control: a controlled trial in subjects with type 2 diabetes. Eur J Clin Nutr, 56(11): 1137-42   2002
  31. Iarussi D, Auricchio U, Agretto A, Murano A, Giuliano M, Casale F, et al. Protective effect of Coenzym Q on anthracylines cardiotoxicity: Control study in children with acute lymphoblastic leukemia and non-hodgkin lymphoma. Molec Aspects Med. 1994;15(Suppl):S207-S212.
  32. Imagawa M, Naruse S, Tsuji S, et al. Coenzym Q10, iron, and vitamin B6 in genetically-confirmed Alzheimer’s disease. Lancet 1992;340:671 [letter].
  33. Jolliet P, Simon N, Barre J, et al. Plasma Coenzym Q10 concentrations in breast cancer: prognosis and therapeutic consequences. Int J Clin Pharmacol Therapeu. 1998;36:506-509.
  34. Judy WV. Nutritional intervention in cancer prevention and treatment. American College for Advancement in Medicine Spring Conference, Ft. Lauderdale, FL. May 3, 1998
  35. Kaikkonen J, Nyyssonen K, Porkkala-Sarataho E, et al. Effect of oral Coenzym Q10 on the oxidation resistance of human VLDL + LDL fraction: absorption and antioxidative properties of oil and granule-based preparations. Free Radic Biol Med 1997;22:1195–202.
  36. Kamikawa T, et al. Effects of Coenzym Q10 on Exercise Tolerance in Chronic Stable Angina Pectoris. Am J Cardiol. Aug1985;56(4):247-51.
  37. Kelly GS. Sport nutrition: a review of selected nutritional supplements for endurance athletes. Altern Med Rev 1997;2:282–95.
  38. Khatta M, Alexander BS, Krichten CM, et al. The effect of Coenzym Q10 in patients with congestive heart failure. Ann Intern Med 2000;132:636–40.
  39. Kishi T, et al. Inhibition of Myocardial Respiration by Psychotherapeutic Drugs and Prevention by Coenzym Q10. In: Yamamura Y, Folkers K, Ito Y, eds. Biomedical and Clinical Aspects of Coenzym Q10. Vol. 2. Amsterdam: Elsevier/North-Holland Biomedical Press;1980:139-54.
  40. Kupin VI, et al. Stimulation of the Immunological Reactivity of Cancer Patients by Eleutherococcus Extract. Vopr Onkol. 1986;32(7):21-26.
  41. Landbo C, Almdal TP. [Interaction between warfarin and Coenzym Q10 (see comments)]. Ugeskr Laeger. 1998;160(22):3225-3227.
  42. Langsjoen H, Langsjoen P, Langsjoen P, et al. Usefulness of Coenzym Q10 in clinical cardiology: a long-term study. Mol Aspects Med. 1994;15(Suppl):s165-75.
  43. Langsjoen P, et al. Treatment of Essential Hypertension with Coenzym Q10. Mol Aspects Med. 1994;15(Suppl):S265-72.
  44. Langsjoen PH, et al. A Six-year Clinical Study of Therapy of Cardiomyopathy with Coenzym Q10. Int J Tissue React. 1990;12(3):169-71.
  45. Larsson O. Effects of isoprenoids on growth of normal human mammary epithelial cells and breast cancer cells in vitro. Anticancer Res 1994;114:123–8.
  46. Lewin A, Lavon H. The effect of Coenzym Q10 on sperm motility and function. Mol Aspects Med. 1997;18(Suppl):S213-9.
  47. Lockwood K, et al. Progress on therapy of Breast Cancer with Vitamin Q10 and the Regression of Metastases. Biochem Biophys Res Commun. Jul1995;212(1):172-77.
  48. Lockwood K, Moesgaard S, Folkers K. Partial and complete regression of breast cancer in patients in relation to dosage of Coenzym Q10. Biochem Biophys Res Commun 1994;199:1504–8.
  49. Lockwood K, Moesgaard S, Yamamoto T, Folkers K. Progress in therapy of breast cancer with vitamin Q10 and the regression of metastases. Biocehmical and Biophysical Research Communications. 1995;212(1):172-177.
  50. Maslova LV, et al. Cardioprotective Effects of Adaptogens of Plant Origin. Biull Eksp Biol Med. 1993;115(3):269-71.
  51. Matthews RT, Yang L, Browne S, Baik M, Beal MF. Coenzym Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects. Proc Natl Acad Sci USA. July 21, 1998; 95:8892-8897.
  52. McGuffin M, Hobbs C, Upton R, Goldberg A. American Herbal Products Association’s Botanical Safety Handbook. Boca Raton, FL: CRC Press, 1997, 45.
  53. McNaughton L. A comparison of Chinese and Russian Siberian ginseng as ergogenic aids to improve various facets of physical fitness. Int Clin Nutr Rev 1989;9:32–5.
  54. McRae S. Elevated serum digoxin levels in a patient taking digoxin and Siberian Siberian ginseng. Can Med Assoc J 1996;155:293–5.
  55. Minkova M, et al. Effect of Eleutherococcus Extract on the Radioprotective Action of Adeturone. Acta Physiol Pharmacol Bulg. 1987;13(4):66-70.
  56. Miyake Y, Shouzu A, Nishikawa M, et al. Effect of treatment of 3-hydroxy-3-methylglutaryl Coenzym I reductase inhibitors on serum Coenzym Q10 in diabetic patients. Arzneimittelforschung 1999;49:324–9.
  57. Møller T & al ,Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease. Neurosci Lett, 341(3): 201-4   2003
  58. Morisco C & al. Effect of coenzyme Q10 therapy in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig, 71(8 Suppl): S134-6   1994
  59. Morisco C, Trimarco B, Condorelli M. Effect of Coenzym Q10 in patients with congestive heart failure: a long-term multicenter randomized study. Clin Investig 1993;71:S134–6.
  60. Mortensen SA, Leth A, Agner E, Rohde M. Dose-related decrease of serum Coenzym Q10 during treatment with HMG-CoA reductase inhibitors. Mol Aspects Med. 1997;18 Suppl:S137-44.
  61. Mortensen SA, Vadhanavikit S, Baandrup U, Folkers K. Long-term Coenzym Q10 therapy: a major advance in the management of resistant myocardial failure. Drug Exptl Clin Res 1985;11:581–93.
  62. Mortensen SA. Perspectives on therapy of cardiovascular diseases with Coenzym Q10 (ubiquinone). Clin Invesigt 1993;71:S116–23 [review].
  63. Murray MT, Pizzorno JE. Encyclopedia of Natural Medicine. 2nd ed. Rocklin, Calif: Prima Publishing; 1996.
  64. Murray MT. Encyclopedia of Nutritional Supplements. Rocklin, Calif: Prima Publishing; 1996:296-308.
  65. Niibori K, Yokoyama H, Crestanello JA, Whitman GJ. Acute administration of liposomal Coenzym Q10 increases myocardial tissue levels and improves tolerance to ischemia reperfusion injury. J Surg Res. 1998;79:141-145.
  66. Oda T. Effect of Coenzym Q10 on Stress-induced Cardiac Dysfunction in Paediatric Patients with Mitral Valve Prolapse: A Study by Stress Echocardiography. Drugs Exp Clin Res. 1985;11(8):557-76.
  67. PDR for Herbal Medicines, 2nd ed. Montvale, NJ: Medical Economics Company; 2000:694.
  68. Permanetter B, Rossy W, Klein G, et al. Ubiquinone (Coenzym Q10) in the long-term treatment of idiopathic dilated cardiomyopathy. Eur Heart J 1992;13:1528–33.
  69. Portakal O, Inal-Erden M. Effects of pentoxifylline and Coenzym Q10 in hepatic ischemia/reperfusion injury. Clin Biochem. 1999;32:461-466.
  70. Shigeta Y, Izumi K, Abe H. Effect of Coenzym Q7 treatment on blood sugar and ketone bodies of diabetics. J Vitaminol 1966;12:293–8.
  71. Shils ME, Olson JA, Shike M, Ross AC. Modern Nutrition in Health and Disease. 9th ed. Baltimore, Md: Williams & Wilkins; 1999:90-92: 1377-1378.
  72. Shinozawa S, Kawasaki H, Gomita Y. [Effect of biological membrane stabilizing drugs (Coenzym Q10, dextran sulfate and reduced glutathione) on adriamycin (doxorubicin)-induced toxicity and microsomal lipid peroxidation in mice]. Gan To Kagaku Ryoho. 1996;23(1):93-98.
  73. Shults CW  & al.Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Arch Neurol, 59(10): 1541-50   2002
  74. Shults CW, Haas RH, Beal MF. A possible role of Coenzym Q10 in the etiology and treatment of Parkinson's disease. Biofactors. 1999;9(2-4):267-72.
  75. Sinatra ST. Coenzym Q10: A Vital Therapeutic Nutrient for the Heart with Special Application in Congestive Heart Failure. Conn Med. Nov1997;61(11):707-11.
  76. Singh RB & al.Randomized, double-blind placebo-controlled trial of coenzyme Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther, 12(4): 347-53   1999
  77. Singh RB, Niaz MA, Rastogi SS, Shukla PK, Thakur AS. Effect of hydrosoluble Coenzym Q10 on blood pressures and insulin resistance in hypertensive patients with coronary artery disease. J Hum Hypertens. 1999;13(3):203-208.
  78. Singh RB, Wander GS, Rastogi A, et al. Randomized, double-blind placebo-controlled trial of Coenzym Q10 in patients with acute myocardial infarction. Cardiovasc Drugs Ther. 1998;12:347-353.
  79. Soja AM, Mortensen SA. Treatment of chornic cardiac insufficiency with Coenzym Q10, results of meta-analysis in controlled clinical trials. Ugeskr Laeger 1997;159:7302–8.
  80. Sosnova TL. The Effect of Eleutherococcus spinosus on the Color Discrimination Function of the Visual Analyzer in Persons with Normal Trichromatic Vision. Vestn Oftalmol. 1969;82(5):59-61.
  81. Spigset O. Reduced effect of warfarin caused by ubidecarenone. The Lancet. 1994;344:1372-1373.
  82. Takahashi N, Iwasaka T, Sugiura T, et al. Effect of Coenzym Q10 on hemodynamic response to ocular timolol. J Cardiovasc Pharmacol. 1989;14:462-468.
  83. Tanaka J, Tominaga R, Yoshitoshi M, et al. Coenzym Q10: the prophylactic effect on low cardiac output following cardiac valve replacement. Ann Thorac Surg 1982;33:145–51.
  84. Tanimura J. Studies on arginine in human semen. Part III. The influences of several drugs on male infertility. Bull Osaka Med School 1967;12:90–100.
  85. Tenchova VB, et al. Changes in Hemopoiesis in the Rat as a Result of Combined Exposure to Acceleration, Irradiation and Radiation-modifying Agents. Kosm Biol Aviakosm Med. 1987;21(2):85-86.
  86. Thomas SR, Neuzil J, Stocker R. Inhibition of LDL oxidation by ubiquinol-10. A protective mechanism for Coenzym Q in atherogenesis? Mol Aspects Med 1997;18:S85–103.
  87. Thorsteindottir B, Rafnsdottir S, Geirsson AJ, et al. No difference in ubiquinone concentration of muscles and blood in fibromyalgia patients and healthy controls. Clin Exp Rheumatol 1998;16:513–4.
  88. Tran MT, Mitchell TM, Kennedy DT, Giles JT. Role of Coenzym Q10 in chronic heart failure, angina, and hypertension. Pharmacotherapy. Jul2001;21(7):797-806.
  89. Tsubaki K, et al. Investigation of the Preventive Effect of CoQ10 against the Side-effects of Anthracycline Antineoplastic Agents. Gan To Kagaku Ryoho. Jul1984;11(7):1420-27.
  90. van Gaal L, et al. Explatory Study of Coenzym Q10 in Obesity. In: Folkers K, Yamamura Y, eds: Biomedical and Clinical Aspects of Coenzym Q10. Vol 4. Amsterdam: Elsevier Science Publications; 1984:369-73.
  91. Wagner H, Nörr H, Winterhoff H. Plant adaptogens. Phytomed 1994;1:63–76 [review].
  92. Watson PS, Scalia GM, Galbraith A, et al. Lack of effect of Coenzym Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 1999;33:1549–52.
  93. Weber C, Jakobsen TS, Mortensen SA, et al. Antioxidative effect of dietary Coenzym Q10 in human blood plasma. Int J Vitam Nutr Res 1994;64:311–5.
  94. Weiss M, Mortensen SA, Rassig MR, et al. Bioavailability of four oral Coenzym Q10 formulations in healthy volunteers. Molec Aspects Med 1994;15:273–80.
  95. Werbach MR. Nutritional Influences on Illness. 2nd ed. Tarzana, Calif: Third Line Press; 1993:66, 119, 122, 179, 421.
  96. Werbach MR. Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev. Apr2000;5(2):93-108.
  97. Ylikoski T & al. The effect of coenzyme Q10 on the exercise performance of cross-country skiers. Mol Aspects Med, 18 Suppl(): S283-90   1997  
  98. Zhou Q, Chan E. Accuracy of repeated blood sampling in rats: A new technique applied in pharmacokinetic/pharmacodynamic studies of the interaction between warfarin and Co-enzyme Q10. J Pharmacol Toxicol Methods. 1998;40(4):191-199. & many more.